Novozymes A/S (OTCMKTS:NVZMY) Sees Unusually-High Trading Volume – What’s Next?

Shares of Novozymes A/S (OTCMKTS:NVZMYGet Free Report) saw an uptick in trading volume on Thursday . 222,710 shares were traded during trading, an increase of 169% from the previous session’s volume of 82,759 shares.The stock last traded at $54.57 and had previously closed at $53.96.

Novozymes A/S Stock Performance

The company has a debt-to-equity ratio of 0.26, a quick ratio of 1.00 and a current ratio of 1.61. The company has a market cap of $22.60 billion, a P/E ratio of 38.94, a P/E/G ratio of 0.99 and a beta of 1.11. The firm has a 50 day moving average price of $61.15 and a 200-day moving average price of $62.02.

Novozymes A/S (OTCMKTS:NVZMYGet Free Report) last issued its quarterly earnings data on Wednesday, February 25th. The biotechnology company reported $0.35 earnings per share for the quarter, missing analysts’ consensus estimates of $0.79 by ($0.44). The company had revenue of $1.18 billion during the quarter, compared to the consensus estimate of $1.22 billion. Novozymes A/S had a net margin of 13.96% and a return on equity of 6.38%. On average, research analysts predict that Novozymes A/S will post 1.82 EPS for the current year.

About Novozymes A/S

(Get Free Report)

Novozymes A/S is a Danish biotechnology company that develops, produces and markets industrial enzymes and microorganisms. Headquartered in Bagsværd, Denmark, the company focuses on using biological solutions to improve industrial processes across a range of end markets. Its offerings are designed to increase product performance or process efficiency while reducing energy, water and chemical consumption for customers.

The company’s product portfolio includes enzymes and microbial solutions for household care (detergents and cleaning products), food and beverages (baking, brewing and dairy applications), bioenergy (enzymes for biofuel production), agriculture (microbial crop inputs and biocontrols) and industrial processing (textiles, pulp and paper, and wastewater treatment).

See Also

Receive News & Ratings for Novozymes A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novozymes A/S and related companies with MarketBeat.com's FREE daily email newsletter.